Home › Research › Risk factors
The Function of Sleep and the Treatment of Primary Insomnia
Wolfgang Freund, Frank Weber. Deutsches Arzteblatt international, 2023-12-15
Topic: Drug trials: efficacy and safety
Plain-language summary
The important functions of sleep include cleaning processes such as the elimination of metabolic products, e.g., amyloid, via the glymphatic system; consolidation of memory; and anabolic regulation of metabolism. Osteoporosis, which affects 10.5% of post-menopausal women, is much more common in those who have insomnia (odds ratio 9.3, 95% confidence interval [2.9; 29.6]). Among 82-year-old persons in good cognitive health, 13% of those who sleep best will go on to develop Alzheimer’s disease, compared to 20% of those who sleep worst. Hypnotic drugs and behavioral therapy can each prolong sleep by approximately 30 minutes. Drugs alter the architecture and function of sleep and have unfavorable consequences, such as a higher rate of falls (healthy individuals: 24.8 per 1000 person-years; persons with insomnia, 27.5; persons taking hypnotic drugs for insomnia, 33.0). Behavioral therapy is resource-intensive and requires the patient’s adherence, yet it has been demonstrated to be effective over the long term and is the treatment of choice. Behavioral therapy is underused despite clear evidence of efficacy, while drugs are given too often. Better patient education and the use of digital applications might help increase the utilization of behavioral therapy for insomnia.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Freund, W., & Weber, F. (2023). The Function of Sleep and the Treatment of Primary Insomnia. Deutsches Arzteblatt international. https://doi.org/10.3238/arztebl.m2023.0228
Vancouver
Freund W, Weber F. The Function of Sleep and the Treatment of Primary Insomnia. Deutsches Arzteblatt international. 2023. doi:10.3238/arztebl.m2023.0228. PMID: 37942822.
BibTeX
@article{freund2023-37942822,
author = {Freund, Wolfgang and Weber, Frank},
title = {{The Function of Sleep and the Treatment of Primary Insomnia}},
journal = {Deutsches Arzteblatt international},
year = {2023},
doi = {10.3238/arztebl.m2023.0228},
pmid = {37942822},
url = {https://doi.org/10.3238/arztebl.m2023.0228}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The important functions of sleep include cleaning processes such as the elimination of metabolic products, e.g., amyloid, via the glymphatic system; consolidation of memory; and anabolic regulation of metabolism.
- Osteoporosis, which affects 10.5% of post-menopausal women, is much more common in those who have insomnia (odds ratio 9.3, 95% confidence interval [2.9; 29.6]).
- Among 82-year-old persons in good cognitive health, 13% of those who sleep best will go on to develop Alzheimer’s disease, compared to 20% of those who sleep worst.
- Hypnotic drugs and behavioral therapy can each prolong sleep by approximately 30 minutes.
- Drugs alter the architecture and function of sleep and have unfavorable consequences, such as a higher rate of falls (healthy individuals: 24.8 per 1000 person-years; persons with insomnia, 27.5; persons taking hypnotic drugs for insomnia, 33.0).
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Effect size10.5%
- Evidence strengthLow
How this study scored 45/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 25 of the 56 points we could judge it on, which is 45 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Deutsches Arzteblatt international) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 37942822) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 25 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 25 of the 56 points we could judge it on is 45 out of 100. |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also tagged “apnea”
196 studies in the library carry the topic tag “apnea”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 196 tagged studies.